Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
For the full year,net profit declined 10.79% to Rs 267.87 crore in the year ended March 2025 as against Rs 300.28 crore during the previous year ended March 2024. Sales rose 13.91% to Rs 1197.58 crore in the year ended March 2025 as against Rs 1051.35 crore during the previous year ended March 2024.
Cohance Lifesciences has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the inspection conducted at its API Unit-IV, located at Plot No. A-21, Road No. 10, IDA Nacharam, Uppal Mandal, Medchal-Malkajgiri, Telangana, India, from 03 March 2025 to 07 March 2025.
The inspection was classified as Voluntary Action Indicated (VAI) and indicates the formal closure of the inspection process by the USFDA.
Sun Pharmaceutical Industries Ltd fell 5.32% today to trade at Rs 1652.1. The BSE Healthcare index is down 0.15% to quote at 41162.29. The index is up 1.89 % over last one month. Among the other constituents of the index, Suven Pharmaceuticals Ltd decreased 2.05% and Lupin Ltd lost 1.8% on the day. The BSE Healthcare index went up 18.64 % over last one year compared to the 11.79% surge in benchmark SENSEX.
Sun Pharmaceutical Industries Ltd has lost 2.1% over last one month compared to 1.89% gain in BSE Healthcare index and 8.08% rise in the SENSEX. On the BSE, 37794 shares were traded in the counter so far compared with average daily volumes of 37750 shares in the past one month. The stock hit a record high of Rs 1960.2 on 30 Sep 2024. The stock hit a 52-week low of Rs 1376.75 on 04 Jun 2024.